Organon Tempers Expectations Ahead Of Adalimumab Second Wave

Firm Prepares To Launch Both High- And Low-Concentration US Humira Biosimilars

 
• By Dave Wallace
  
Skate ramp gradually ramping up
Organon expects a “modest ramp” for Hadlima in the US • Source: Shutterstock

More from Biosimilars

More from Products